Physician profile
Andrew A Seltzer
NPI 1124127055
$9,861.63
in general payments reported to CMS, 2019-2025
17 companies · $3,731 in 2025
The $3,731 reported for 2025 was more than what 89% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,437 · 2020: $90.39 · 2021: $1,285 · 2022: $469 · 2023: $651 · 2024: $197 · 2025: $3,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,329 · Travel and Lodging: $2,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,329.40 |
| Travel and Lodging | $2,250.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,681.44 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $2,549.40 | 2023-2025 | Persona, Rosa, Mymobility Platform |
| Southern Edge Orthopaedics, INC. | $1,670.66 | 2019-2025 | |
| Smith+Nephew, INC. | $877.45 | 2019-2025 | Evos, Ascension, Nugrip Cmc Implant System |
| Stryker Corporation | $424.21 | 2019-2024 | Variax |
| Orthofix Medical, INC. | $129.52 | 2024 | Physio-Stim, Spinal-Stim |
| Bioventus LLC | $90.53 | 2021-2025 | Xcell, L360 Thigh System |
| Abbott Laboratories | $77.81 | 2022 | |
| Medtronic, INC. | $76.84 | 2022-2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Embody, INC. | $71.43 | 2022 | |
| Endo Pharmaceuticals INC. | $59.52 | 2019-2022 | |
| Abbvie INC. | $41.58 | 2021 | |
| Horizon Therapeutics Plc | $24.89 | 2021-2022 | |
| Djo, LLC | $24.63 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $23.48 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $22.95 | 2024 | Trivisc Sodium Hyaluronate |
| Pacira Therapeutics, INC. | $15.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Seltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.